姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Cai,Zheng-Xian | Chairman | 32.64% | Bionet Corporation(Bionet Corp.) |
Zhang,Cui-Ru | Director | 5.78% | GENETICS GENERATION ADVANCEMENT CORP. (GGA CORP.) |
Liang,Yu-Lun | Director | 1.43% | CHIEN HSIN TRADING CO., LTD. |
Zhang,Wen-Zheng | Director | 0.88% | |
Sheng,Bao-Xi | Director | 1.43% | Baolei Co. Ltd. |
Lin,Pi-Rong | Independent Director | 0.00% | |
Zhuang,Fu-Jun | Independent Director | 0.00% | |
LING STEVEN DEE | Independent Director | 0.00% | |
Lin,Kun-Ming | Independent Director | 0.00% |
項目 | 2024 | 2023 |
---|---|---|
Operating income | 81,319 | 5,369 |
Operating cost | 79,301 | 3,571 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - |
Operating gross profit (loss) | 2,018 | 1,798 |
Unrealized profit (loss) on sales of goods | - | - |
Realized profit (loss) on sales of goods | - | - |
Operating gross profit (loss), net | 2,018 | 1,798 |
Operating expenses | 101,381 | 41,056 |
Other gain (loss), net | - | - |
Operating profit (loss) | -99,363 | -39,258 |
Non-operating income and expenses | 13,105 | 1,920 |
Net profit (loss) before tax | -86,258 | -37,338 |
Income tax expense (benefits) | 0 | 0 |
Net profit (loss) of ongoing business for the current period | -86,258 | -37,338 |
Profit (loss) of closed units | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - |
Net profit (loss) for the current period | -86,258 | -37,338 |
Other comprehensive profit (loss), net | -5,080 | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - |
Total comprehensive profit and loss for the current period | -91,338 | -37,338 |
Net profit (loss) attributable to owners of parent company | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - |
Net profit (loss) attributable to non-controlling interests | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - |
Basic earnings per share (yuan) | -1 | -2 |
項目 | 2024 | 2023 |
---|---|---|
Net cash inflow (outflow) from operating activities | - | - |
Net cash inflows (outflows) from investing activities | - | - |
Net cash inflow (outflow) from financing activities | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - |
Beginning balance of cash and cash equivalents | - | - |
Ending balance of cash and cash equivalents | - | - |
項目 | 2024 | 2023 |
---|---|---|
Current asset | 1,274,970 | 528,346 |
Non-current asset | 75,052 | 11,835 |
Total asset | 1,350,022 | 540,181 |
Current liability | 53,702 | 12,088 |
Non-current liability | - | - |
Total liability | 53,702 | 12,088 |
share capital | 700,000 | 450,287 |
Equity - secruity token | - | - |
capital reserve | 735,095 | 125,243 |
retained earning | -133,695 | -47,437 |
Other equity | -5,080 | - |
Treasury stock | - | - |
Total equity attributable to owners of parent company | - | - |
Equity attributable to former owner of business combination under common control | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - |
Non-controlling interests | - | - |
Total Equity | 1,296,320 | 528,093 |
Share capital awaiting retirement (unit: share) | 0 | 0 |
Issued shares of advance equity (unit: shares) | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 |
Net asset value per share | 18 | 11 |